Home / Filing-delay notices (10-Q) / Outlook Therapeutics, Inc.
Filed 2026-08-17 路 Form NT 10-Q 路 Accession 0001104659-26-097838 micro
Price before filing: $0.7564 (2026-08-14 close, split/dividend-adjusted)
Market cap at flag: $91.9M (2026-08-17) 路 Latest: $12.4M (2026-10-16)
| Window | OTLK | SPY | vs SPY | |
|---|---|---|---|---|
| 30 days | -10.5% | -2.9% | -7.6% | 2026-09-16 |
| 90 days | pending | pending | until 2026-11-15 | |
| 180 days | pending | pending | until 2027-02-13 | |
| 1 year | pending | pending | until 2027-08-17 |
Return from the last close before the filing date to the first close on/after the window end. Pending windows have not fully elapsed. Past performance says nothing certain about the future.
90 days before the flag: 7 insiders bought $7.9M (10 purchases, 2 without a usable price)
30 days after: none reported.
| Date | Insider | Type | Shares | Price | Value | 10b5-1 plan | Source |
|---|---|---|---|---|---|---|---|
| 2026-05-26 | HILZINGER KURT J Director | Purchase | 400,000 | $0.44 | $177K | no | Form 4 |
| 2026-05-26 | Haddadin Yezan Munther Director | Purchase | 34,000 | $0.44 | $15K | no | Form 4 |
| 2026-05-26 | THURMAN RANDY H Director | Purchase | 5,000 | $0.43 | $2K | no | Form 4 |
| 2026-05-27 | Sukhtian Faisal Ghiath Director | Purchase | 122,174 | $0.41 | $50K | no | Form 4 |
| 2026-05-28 | Sukhtian Ghiath M. (+1 joint filer) Director, 10% owner | Purchase | 8,539,709 | $0.59 | $5.0M | no | Form 4 |
| 2026-06-02 | Haddadin Yezan Munther Director | Purchase | 29,000 | $0.83 | $24K | no | Form 4 |
| 2026-07-29 | Sukhtian Faisal Ghiath Director | Purchase | 95,398 | $1.05 | $100K | no | Form 4 |
| 2026-08-12 | Sukhtian Ghiath M. (+1 joint filer) Director, 10% owner | Purchase | 2,525,252 | $0.99 | $2.5M | no | Form 4 |
| 2026-08-14 | Jahr Robert Charles Chief Executive Officer, Director | Purchase | 151,515 | n/a | n/a | no | Form 4 |
| 2026-08-14 | KENYON LAWRENCE A Chief Financial Officer, Director | Purchase | 101,010 | n/a | n/a | no | Form 4 |
| 2026-08-17: red flag filed | |||||||
Open-market purchases and sales (Form 4 codes P and S) by officers, directors and 10% owners, by transaction date, from 2026-05-19 to 2026-09-16. Excludes option exercises, grants, gifts and tax withholding. Amended filings replace the originals; joint filings count once. Foreign private issuers do not file Form 4. Many insider sales are pre-scheduled (10b5-1 plans) and are not by themselves a sign of wrongdoing.
The company filed Form NT 10-Q, telling the SEC it could not file its quarterly report on time, and then filed the report within the 5-day extension. The SEC treats a report filed within the extension as timely, so this is the mildest kind of flag, but the notice itself is a warning sign that investors often react to: something, often the audit or the accounting, took longer than planned.
Status: filed within extension (report filed 2026-08-18) · the SEC treats a report filed within the extension as timely
Why this score: report filed within the extension on 2026-08-18
Read the original filing on SEC.gov →
🔔 Get email alerts for this company
Not investment advice. Automated summary; verify against the filing.
The week's most serious auditor changes, restatements, late filings and going-concern warnings, in plain English. Free. Unsubscribe anytime.
Subscribe to the newsletter →
The signup form didn't load here (often an ad or privacy blocker). This opens beehiiv's secure signup page.
Form not showing? Subscribe on beehiiv →
Newsletter delivered by beehiiv. See our privacy policy.